March 17, 2023
The Japanese health ministry on March 16 presented the number of health damages reported for regenerative medicine products in April-September 2022, with Novartis’ CAR-T cell therapy Kymriah (tisagenlecleucel) recording the highest figure in Japan with 97 cases. According to the...read more